Acquisitions in Styria, Austria

Showing 4 transactions.

  • Headwall Group Acquires EVK DI Kerschhaggl GmbH
    January 14, 2025
    Buyer
    Headwall Group, Arsenal Capital Partners
    Target
    EVK DI Kerschhaggl GmbH
    Location
    Styria, Austria
    Type
    Addon

    Headwall Group, a Bolton, Massachusetts-based portfolio company of Arsenal Capital Partners, has acquired Austria-based EVK DI Kerschhaggl GmbH (EVK), a developer of industrial sensor-based sorting and inspection systems. The acquisition expands Headwall's hyperspectral imaging and sensor capabilities to better serve markets such as food processing, plastics recycling, and material sorting.

  • Clubessential Holdings Acquires TAC (The Assistant Company)
    March 2, 2022
    Buyer
    Clubessential Holdings LLC
    Target
    TAC (The Assistant Company)
    Industry
    Cloud & SaaS
    Location
    Styria, Austria
    Type
    Addon

    Clubessential Holdings acquired TAC (The Assistant Company), a Hartberg, Austria–based provider of spa, membership and access-control SaaS, expanding Clubessential's global footprint and adding spa and leisure capabilities. The deal increases Clubessential's international presence and customer reach in the spa, fitness and hospitality markets.

  • System Seals Acquires Plastoseal Produktions GmbH
    August 24, 2021
    Buyer
    System Seals Inc.
    Target
    Plastoseal Produktions GmbH
    Industry
    Manufacturing
    Location
    Styria, Austria
    Type
    Buyout

    Cleveland-based System Seals Inc. has acquired Plastoseal Produktions GmbH, an Austrian manufacturer of engineered seals and plastic components, to expand its presence in Europe and broaden its GlobalOne supply-chain program. Plastoseal’s founder Wolfgang Kerschbaumer will remain as managing director as the companies integrate product ranges and R&D capabilities.

  • QPS Acquires JSW Life Sciences
    August 29, 2012
    Buyer
    QPS, LLC
    Target
    JSW Life Sciences GmbH
    Location
    Styria, Austria
    Type
    Buyout

    QPS, LLC acquired a majority interest in JSW Life Sciences GmbH and will operate the business as QPS JSW. The deal expands QPS's preclinical capabilities (including CNS/transgenic models) and Phase II–IV clinical operations while strengthening its presence in Central and Eastern Europe.